EGFRT - Overview: EGFR Gene, Mutation Analysis, 29 Mutation Panel, Tumor

Test Catalog

Test Name

Test ID: EGFRT    
EGFR Gene, Mutation Analysis, 29 Mutation Panel, Tumor

Useful For Suggests clinical disorders or settings where the test may be helpful

Identifying non-small cell lung cancers that may respond to epidermal growth factor receptor-tyrosine kinase inhibitor therapies

Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)

Test IDReporting NameAvailable SeparatelyAlways Performed
SLIRVSlide Review in MGNo, (Bill Only)Yes

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, slide review will always be performed at an additional charge.

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Analysis

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

EGFR Gene, Mutation Analysis, Tumor

Aliases Lists additional common names for a test, as an aid in searching

EGFR
EGFR-TKI
EGFR-tyrosine kinase inhibitor
Epidermal growth factor receptor
Erlotinib
Gefitinib
Non-small cell lung cancer
NSCLC
T790M